LncRNA HCG18 Promotes Osteosarcoma Cells Proliferation, Migration, and Invasion in by Regulating miR-34a/RUNX2 Pathway
Author:
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine,Ecology, Evolution, Behavior and Systematics,Biochemistry
Link
https://link.springer.com/content/pdf/10.1007/s10528-022-10294-5.pdf
Reference36 articles.
1. Alessandro F, Irene B (2014) Long non-coding RNAs: new players in cell differentiation and development. Nat Rev Genet 15:7–21
2. Chen X et al (2016) MiR-34a and miR-203 inhibit survivin expression to control cell proliferation and survival in human osteosarcoma cells. J Cancer 7:1057–1065
3. Deng Y, Zhao F, Zhang Z, Sun F, Wang M (2018) Long noncoding RNA snhg7 promotes the tumor growth and epithelial-to-mesenchymal transition via regulation of miR-34a signals in osteosarcoma. Cancer Biother Radiopharm 33:365–372. https://doi.org/10.1089/cbr.2018.2503
4. Fu D et al (2019) LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis. Aging (albany NY) 11:8374–8385. https://doi.org/10.18632/aging.102325
5. Gao Y, Zhang B, Wang Y, Shang G (2018) Cdc20 inhibitor apcin inhibits the growth and invasion of osteosarcoma cells. Oncol Rep. https://doi.org/10.3892/or.2018.6467
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role of lncRNA HCG18 in human diseases;Cell Biochemistry and Function;2024-02-29
2. LINC00960 affects osteosarcoma treatment and prognosis by regulating the tumor immune microenvironment;Heliyon;2024-02
3. LncRNA HCG18 promotes prostate cancer progression by regulating miR-512-3p/HK-2 axis;Asian Journal of Urology;2024-02
4. MicroRNA-34 Family in Cancers: Role, Mechanism, and Therapeutic Potential;Cancers;2023-09-26
5. RUNX2 and Cancer;International Journal of Molecular Sciences;2023-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3